Altimmune Net Tangible Assets from 2010 to 2024
| ALT Stock | USD 7.68 0.22 2.95% |
Check Altimmune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Altimmune's main balance sheet or income statement drivers, such as , as well as many indicators such as . Altimmune financial statements analysis is a perfect complement when working with Altimmune Valuation or Volatility modules.
Altimmune |
About Altimmune Financial Statements
Altimmune shareholders use historical fundamental indicators, such as Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Altimmune investors may analyze each financial statement separately, they are all interrelated. The changes in Altimmune's assets and liabilities, for example, are also reflected in the revenues and expenses on on Altimmune's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland. Altimmune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.